OncoCyte Corporation (OCX)
NASDAQ: OCX · Real-Time Price · USD
2.190
-0.020 (-0.91%)
Dec 20, 2024, 4:00 PM EST - Market closed
OncoCyte Market Cap
OncoCyte has a market cap or net worth of $36.87 million as of December 20, 2024. Its market cap has increased by 16.31% in one year.
Market Cap
36.87M
Enterprise Value
37.50M
1-Year Change
16.31%
Ranking
Category
Stock Price
$2.19
Market Cap Chart
Since January 4, 2016, OncoCyte's market cap has decreased from $228.70M to $36.87M, a decrease of -83.88%. That is a compound annual growth rate of -18.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 36.90M | 78.26% |
| Dec 29, 2023 | 20.70M | -45.67% |
| Dec 30, 2022 | 38.10M | -80.96% |
| Dec 31, 2021 | 200.10M | 24.52% |
| Dec 31, 2020 | 160.70M | 37.47% |
| Dec 31, 2019 | 116.90M | 108.38% |
| Dec 31, 2018 | 56.10M | -61.60% |
| Dec 29, 2017 | 146.10M | -27.82% |
| Dec 30, 2016 | 202.40M | -11.50% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aileron Therapeutics | 38.13M |
| AN2 Therapeutics | 37.95M |
| CalciMedica | 37.34M |
| Envoy Medical | 37.25M |
| Enzo Biochem | 37.22M |
| Elevation Oncology | 36.99M |
| BioVie | 36.90M |
| OKYO Pharma | 36.88M |